Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
出版年份 2011 全文链接
标题
Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 11, Issue 10, Pages 1381-1394
出版商
Informa Healthcare
发表日期
2011-08-08
DOI
10.1517/14712598.2011.605352
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: A double-blind, placebo-controlled study
- (2011) W. H. Abdulahad et al. ARTHRITIS AND RHEUMATISM
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
- Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
- (2011) P. Engel et al. PHARMACOLOGICAL REVIEWS
- What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?
- (2011) Cees GM Kallenberg et al. ARTHRITIS RESEARCH & THERAPY
- Belimumab: A BLyS-Specific Inhibitor for Systemic Lupus Erythematosus
- (2010) Amy K Wiglesworth et al. ANNALS OF PHARMACOTHERAPY
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial
- (2010) J. M. Meijer et al. ARTHRITIS AND RHEUMATISM
- Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab
- (2010) Valérie Devauchelle-Pensec et al. ARTHRITIS AND RHEUMATISM
- B-cell tolerance breakdown in Sjögren's Syndrome: Focus on BAFF
- (2010) Marie-Michèle Varin et al. AUTOIMMUNITY REVIEWS
- Rituximab in Hodgkin lymphoma: Is the target always a hit?
- (2010) Kamal S. Saini et al. CANCER TREATMENT REVIEWS
- Rituximab
- (2010) Gillian M. Keating DRUGS
- Autoimmune response and target autoantigens in Sjogren’s syndrome
- (2010) John G. Routsias et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Does rituximab increase the incidence of infectious complications? A narrative review
- (2010) Theodoros Kelesidis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Treatment Approaches in Primary Sjögren Syndrome
- (2010) Arjan Vissink et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of Primary Sjögren Syndrome
- (2010) Manuel Ramos-Casals et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Regulation of the B Cell Receptor Repertoire and Self-Reactivity by BAFF
- (2010) M. Ota et al. JOURNAL OF IMMUNOLOGY
- Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
- (2010) P. J. MEASE et al. JOURNAL OF RHEUMATOLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment
- (2009) J M Meijer et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
- (2009) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome
- (2009) J. Pijpe et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- BAFF: a local and systemic target in autoimmune diseases
- (2009) I. Moisini et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- New ELISA for B Cell-Activating Factor
- (2009) L. Le Pottier et al. CLINICAL CHEMISTRY
- Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets
- (2009) Jennifer H. Anolik et al. IMMUNOLOGIC RESEARCH
- CD20 deficiency in humans results in impaired T cell–independent antibody responses
- (2009) Taco W. Kuijpers et al. JOURNAL OF CLINICAL INVESTIGATION
- Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjögren Syndrome
- (2009) Evangelia Baimpa et al. MEDICINE
- Health-related quality of life, employment and disability in patients with Sjögren's syndrome
- (2009) Jiska M. Meijer et al. RHEUMATOLOGY
- Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines
- (2009) R Baturone et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells
- (2008) Manon E. Wildenberg et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways
- (2008) Marc Ittah et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients
- (2008) S. Lovric et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between IFN-α and primary Sjogren's syndrome
- (2008) Lingyan Zheng et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
- Safety of Biologic Therapy in Rheumatoid Arthritis and Other Autoimmune Diseases: Focus on Rituximab
- (2008) Roy M. Fleischmann SEMINARS IN ARTHRITIS AND RHEUMATISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started